The bill focuses on the reimbursement of prescription drugs under Medicaid and the Child Health Plan Program. It aims to address issues related to drug reimbursement within these programs. The main provisions likely include changes to how prescription drugs are priced and reimbursed, potentially impacting access to medications for Medicaid and Child Health Plan Program beneficiaries. The bill may propose measures to control costs, ensure transparency in pricing, or improve drug accessibility for individuals covered by these programs.
2023-01-12: Filed
2023-03-03: Read first time
2023-03-03: Referred to Human Services
2023-04-25: Scheduled for public hearing on . . .
2023-04-25: Considered in public hearing
2023-04-25: Testimony taken/registration(s) recorded in committee
2023-04-25: Left pending in committee
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..